Seth Feldman

Seth Feldman currently serves as Vice President and Global Head of New Product Strategy & Innovation at Ipsen, a position held since January 2025. Previously, Feldman was Vice President of Marketing and New Product Development at Syros Pharmaceuticals, where responsibilities included guiding the launch team for the oncology product tamibarotene and overseeing all aspects of its commercial planning. Prior experience at AstraZeneca included roles as Global Commercial Lead for the DDR Franchise in Oncology, where strategic initiatives maximized the value of oncology assets, and leadership positions focused on precision medicine, access strategy, and portfolio growth. Early career experience involved marketing leadership at MedImmune and Vanda Pharmaceuticals, where Feldman successfully launched products and managed P&L responsibilities. Feldman earned an MBA in Marketing and Management from Columbia Business School and a BA in East Asian History from Brown University.